Emily Field, Barclays head of European pharmaceutical research, joins CNBCs The Exchange to discuss why Novo Nordisk shares are falling, the competition







Novo Nordisk: Why the stock of the Danish pharmaceutical giant is plunging [wqlTvW-HVuu]

Novo Nordisk: Why the stock of the Danish pharmaceutical giant is plunging [wqlTvW-HVuu]

| 1h 28m 28s | Video has closed captioning.

Emily Field, Barclays head of European pharmaceutical research, joins CNBC's 'The Exchange' to discuss why Novo Nordisk shares are falling, the competition in the weight-loss drug space, and more. #reviews for keto acv #keto metabolism pills #gummie recipe keto trays #gummy bear ketting

Aired: December 22, 2024

Rating: TV-14

Buy Now:

Problems Playing Video? | Closed Captioning

Related to This Episode

  • Q&A with Heidi Thomas

    Q&A with Heidi Thomas

    Writer & Executive Producer of Novo Nordisk: Why the stock of the Danish pharmaceutical giant is plunging [wqlTvW-HVuu] on the secret of the show.

  • Relive the Drama with Gif Recaps

    Relive the Drama with Gif Recaps

    Miss an episode? Catch up on all things Poplar with our gif recaps.

  • Visit the Official Site

    Visit the Official Site

    Dive deeper into Novo Nordisk: Why the stock of the Danish pharmaceutical giant is plunging [wqlTvW-HVuu] with cast Q&As, expert blogs, BTS photos, and more!

  • Explore the Modern Midwives Blog

    Explore the Modern Midwives Blog

    Experienced midwives discuss how Novo Nordisk: Why the stock of the Danish pharmaceutical giant is plunging [wqlTvW-HVuu] intersects with modern day Midwifery.

Learn About Midwifery Today

Blog

Learn About Midwifery Today

Read the Modern Day Midwives Blog and learn more about our bloggers, all experienced midwives.

Read now